US private equity firm Warburg Pincus is nearing a deal to buy Maneesh Pharmaceuticals' non-tuberculosis drug business. The acquisition is valued between ₹1,600 to ₹1,800 crore. This move is part of Warburg's strategy to build a larger pharmaceutical platform…
US-based private equity firm Warburg Pincus is in advanced discussions to acquire the formulations business of Mumbai-based Maneesh Pharmaceuticals in a deal valued around 1,6001,800 crore, sources f… [+3408 chars]




